(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid

Term ID

CHEBI:65136

Synonyms

(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid
(All-Z)-4,7,10,13,16-docosapentaenoic acid
22:5(4Z,7Z,10Z,13Z,16Z)
4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid
all-cis-docosa-4,7,10,13,16-pentaenoic acid
C22:5n-6,9,12,15,18
Docosapentaenoic acid (22n-6)
DPAn-6

Definition

The all-cis-isomer of a C22 polyunsaturated fatty acid having five double bonds in the 4-, 7-, 10-, 13- and 16-positions. It is a member of n-6 PUFA and a product of linoleic acid metabolism.

References

CAS:25182-74-5
CAS:25448-00-4
HMDB:HMDB0001976
HMDB:HMDB0013123
LIPID_MAPS_instance:LMFA04000064
PMID:14643447
PMID:17291553
Reaxys:1715090

Ontology

ChEBI ( EBI )

Resources

CTD

Relationships

is a type of: docosapentaenoic acid omega-6 fatty acid

docosapentaenoic acid omega-6 fatty acid Show first 5 Terms
has_role: algal metabolite Daphnia tenebrosa metabolite human metabolite

algal metabolite Daphnia tenebrosa metabolite human metabolite Show first 5 Terms
inverse has_functional_parent: (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoic acid (4Z,7Z,10Z,12E,16Z)-14-hydroperoxydocosapentaenoic acid (4Z,7Z,10Z,13Z,15E,17S)-17-hydroperoxydocosapentaenoic acid (4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoic acid (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl-CoA ... Show All 15 Terms

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoic acid (4Z,7Z,10Z,12E,16Z)-14-hydroperoxydocosapentaenoic acid (4Z,7Z,10Z,13Z,15E,17S)-17-hydroperoxydocosapentaenoic acid (4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoic acid (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl-CoA (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl-containing glycerolipid (4Z,7Z,11Z,13Z,15E,17S)-10,17-bis(hydroperoxy)docosapentaenoic acid 1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phosphoethanolamine 1-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine 1-[(11Z,14Z)-icosadienoyl]-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phosphocholine 1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3- phosphocholine 1-octadecanoyl-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine 1-octadecyl-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine ethyl (4Z,7Z,10Z,13Z,16Z)-docosapentaenoate Show first 5 Terms
inverse is_conjugate_base_of: (4Z,7Z,10Z,13Z,16Z)-docosapentaenoate

(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate Show first 5 Terms
inverse is_substituent_group_from: (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl group

(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl group Show first 5 Terms
is_conjugate_acid_of: (4Z,7Z,10Z,13Z,16Z)-docosapentaenoate

(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate Show first 5 Terms

Phenotype

Phenotype resulting from (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid

Phenotype where environments contain (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid

Phenotype modified by environments containing (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid

Human Disease / Model Data

Citations